Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study - Apolo, AB; Infante, JR; Balmanoukian, A (J Clin Oncol, 2017)